Literature DB >> 1770301

Regulation of gene expression and synthesis and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by micellar cholesterolin CaCo-2 cells.

F J Field1, T Shreves, D Fujiwara, S Murthy, E Albright, S N Mathur.   

Abstract

To investigate whether, and by what mechanisms, luminal (dietary) cholesterol regulates cholesterol synthesis in human intestinal cells, HMG-CoA reductase activity, gene expression, synthesis, and degradation were investigated in CaCo-2 cells exposed to taurocholate micelles containing cholesterol. In cells incubated with cholesterol solubilized in 5 mM taurocholate and 30 microM monoolein, HMG-CoA reductase activity was decreased. 25-Hydroxycholesterol, delivered to the cells in the same manner as native cholesterol, was significantly more potent in inhibiting reductase activity and was used, therefore, to investigate mechanisms for sterol regulation. Cells incubated with taurocholate micelles without cholesterol lost cellular cholesterol into the medium causing an increase in HMG-CoA reductase activity and enzyme mass. Although steady-state levels of HMG-CoA reductase mRNA were increased under conditions of cholesterol efflux, synthesis rates of reductase protein were not increased. An increase in activity and enzyme mass in cells incubated with micelles alone, however, was accompanied by a significant decrease in the rate of degradation of reductase protein. In contrast, sterol influx from taurocholate micelles was associated with a marked decrease in HMG-CoA reductase activity and mass without altering mRNA levels except at high concentrations of the polar sterol which did decrease reductase mRNA levels by 50%. The absorption of apical sterol resulted in a significant decrease in the translational efficiency of reductase mRNA and a modest increase in the rate of degradation of the enzyme. Thus, although the primary function of the enterocyte is to transport luminal (dietary) cholesterol to other tissues of the body, apically derived cholesterol enters metabolic pools within the cell which regulates its own cholesterol synthesis. Dietary cholesterol, therefore, will regulate the contribution to the total body cholesterol pool of endogenously derived cholesterol from the intestine. The mechanism for this regulation of intestinal HMG-CoA reductase by luminal cholesterol occurs primarily at the post-transcriptional level.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1770301

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

Review 1.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

2.  Generating ceramide from sphingomyelin by alkaline sphingomyelinase in the gut enhances sphingomyelin-induced inhibition of cholesterol uptake in Caco-2 cells.

Authors:  Dan Feng; Lena Ohlsson; Wenhua Ling; Ake Nilsson; Rui-Dong Duan
Journal:  Dig Dis Sci       Date:  2010-12       Impact factor: 3.199

3.  Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression.

Authors:  Dan Feng; Lena Ohlsson; Rui-Dong Duan
Journal:  Lipids Health Dis       Date:  2010-04-19       Impact factor: 3.876

4.  Sphingomyelin content of intestinal cell membranes regulates cholesterol absorption. Evidence for pancreatic and intestinal cell sphingomyelinase activity.

Authors:  H Chen; E Born; S N Mathur; F C Johlin; F J Field
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

5.  Synthesis and evaluation of novel amide amino-β-lactam derivatives as cholesterol absorption inhibitors.

Authors:  Tonko Dražić; Vinay Sachdev; Christina Leopold; Jay V Patankar; Martina Malnar; Silva Hećimović; Sanja Levak-Frank; Ivan Habuš; Dagmar Kratky
Journal:  Bioorg Med Chem       Date:  2015-03-31       Impact factor: 3.641

6.  Novel amino-β-lactam derivatives as potent cholesterol absorption inhibitors.

Authors:  Tonko Dražić; Krešimir Molčanov; Vinay Sachdev; Martina Malnar; Silva Hećimović; Jay V Patankar; Sascha Obrowsky; Sanja Levak-Frank; Ivan Habuš; Dagmar Kratky
Journal:  Eur J Med Chem       Date:  2014-10-07       Impact factor: 6.514

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.